192 related articles for article (PubMed ID: 6165744)
1. Antimalarials.
Koranda FC
J Am Acad Dermatol; 1981 Jun; 4(6):650-5. PubMed ID: 6165744
[TBL] [Abstract][Full Text] [Related]
2. [Synthetic antimalarials].
Fardet L; Revuz J
Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):665-74. PubMed ID: 16230916
[TBL] [Abstract][Full Text] [Related]
3. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
Feldmann R; Salomon D; Saurat JH
Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
[TBL] [Abstract][Full Text] [Related]
4. [Antimalarial drugs in contemporary dermatologic therapy].
Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
Mittal L; Zhang L; Feng R; Werth VP
J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
[TBL] [Abstract][Full Text] [Related]
6. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
7. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
von Schmiedeberg S; Rönnau AC; Schuppe HC; Specker C; Ruzicka T; Lehmann P
Hautarzt; 2000 Feb; 51(2):82-5. PubMed ID: 10743578
[TBL] [Abstract][Full Text] [Related]
8. Use of antimalarials in dermatology.
Ochsendorf FR
J Dtsch Dermatol Ges; 2010 Oct; 8(10):829-44; quiz 845. PubMed ID: 20678149
[TBL] [Abstract][Full Text] [Related]
9. Ocular toxicity of antimalarial drugs. Long-term follow-up.
Carr RE; Henkind P; Rothfield N; Siegel IM
Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
[No Abstract] [Full Text] [Related]
10. Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
Schwartzman S; Samson CM
Rheum Dis Clin North Am; 2019 Aug; 45(3):359-367. PubMed ID: 31277749
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.
Geraminejad P; Stone MS; Sontheimer RD
Lupus; 2004; 13(6):473-7. PubMed ID: 15303576
[TBL] [Abstract][Full Text] [Related]
12. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
13. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.
Al-Bari MA
J Antimicrob Chemother; 2015; 70(6):1608-21. PubMed ID: 25693996
[TBL] [Abstract][Full Text] [Related]
14. Optimal use of antimalarials in treating cutaneous lupus erythematosus.
Wozniacka A; McCauliffe DP
Am J Clin Dermatol; 2005; 6(1):1-11. PubMed ID: 15675885
[TBL] [Abstract][Full Text] [Related]
15. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
[TBL] [Abstract][Full Text] [Related]
16. Discoid lupus erythematosus.
Brown RK
Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
[No Abstract] [Full Text] [Related]
17. Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
Tanenbaum L; Tuffanelli DL
Arch Dermatol; 1980 May; 116(5):587-91. PubMed ID: 6990871
[No Abstract] [Full Text] [Related]
18. Antimalarials.
Van Beek MJ; Piette WW
Dermatol Clin; 2001 Jan; 19(1):147-60, ix. PubMed ID: 11155579
[TBL] [Abstract][Full Text] [Related]
19. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
20. [SEVERE RETINOPATHY DURING TREATMENT OF LUPUS ERYTHEMATOSUS BY SYNTHETIC ANTIMALARIALS (2 CASES)].
GRUPPER C; BREGEAT P; JUGE P
Bull Soc Fr Dermatol Syphiligr; 1963; 70():824-32. PubMed ID: 14157895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
